COMPASS Pathways EPS CMPS

Diluted earnings per share by quarter and over the last twelve months, from 2021.

COMPASS Pathways' earnings per share was −$4.60 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$1.88.

Earnings per share over time

Each fiscal year is the twelve months to its fourth quarter.

Quarter	Ended	EPS	On a year earlier	Last 12 months
Q2 FY26	Jun 30, 2026	−$1.88	n/a	−$4.60
Q1 FY26	Mar 31, 2026	−$0.30	n/a	−$3.13
Q4 FY25	Dec 31, 2025	−$0.98	n/a	−$3.07
Q3 FY25	Sep 30, 2025	−$1.44	n/a	−$2.72
Q2 FY25	Jun 30, 2025	−$0.41	n/a	−$1.84
Q1 FY25	Mar 31, 2025	−$0.24	n/a	−$1.99
Q4 FY24	Dec 31, 2024	−$0.63	n/a	−$2.30
Q3 FY24	Sep 30, 2024	−$0.56	n/a	−$2.20
Q2 FY24	Jun 30, 2024	−$0.56	n/a	−$2.31
Q1 FY24	Mar 31, 2024	−$0.55	n/a	−$2.37
Q4 FY23	Dec 31, 2023	−$0.53	n/a	−$2.39
Q3 FY23	Sep 30, 2023	−$0.67	n/a	−$2.59

Companies in Drug Manufacturers - General nearest COMPASS Pathways' size, closest first, today.

Company	EPS, 12 months	Growth
CMPSCOMPASS Pathways	−$4.60
PAHCPhibro Animal Health	$2.44	+107% a year
ANABAnaptysbio	$4.57
PCRXPacira BioSciences	$0.35
ANIPANI Pharmaceuticals	$4.70
OMEROmeros	$1.52
HRMYHarmony Biosciences	$3.09	−0% a year
AMPHAmphastar Pharmaceuticals	$1.70	−36% a year
PBHPrestige Consumer Healthcare	$3.57	−16% a year
NRIXNurix Therapeutics	$2.31
ABUSArbutus Biopharma	$0.78
Peer median	$2.38